Research
Search by Keyword or Filter Below
Try Ask ZenPsy our Advanced AI Powered Search!
We found 1001 articles that match your request.
LSD
Large-scale brain connectivity changes following the administration of LSD, d-amphetamine and MDMA
Mol Psychiatry. 2025 25-Nov;():. 10.1038/s41380-024-02734-y
Ketamine
Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing
Transl Psychiatry. 2024 02-Dec;():. 10.1038/s41398-024-03120-6
Psilocybin
Relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy
Gen Hosp Psychiatry. 2025 02-Dec;():. 10.1016/j.genhosppsych.2025.07.020
MDMA
Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA
JAMA Netw Open. 2025 25-Nov;():. 10.1001/jamanetworkopen.2025.7803
Psilocybin
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises
Mol Psychiatry. 2025 25-Nov;():. 10.1038/s41380-025-03035-8
Psilocybin
Acute psilocybin and ketanserin effects on cerebral blood flow
J Cereb Blood Flow Metab. 2025 25-Nov;():. 10.1177/0271678X251323364
Psilocybin
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment
Clin Pharmacol Ther. 2022 05-Sep;():. 10.1002/cpt.2487
Ketamine
Subanesthetic ketamine alters EEG signal complexity: Implications for treatment stratification in depression
J Affect Disord. 2025 05-Nov;():. 10.1016/j.jad.2025.119477
Ketamine
Acute effects of intranasal esketamine application on thalamic structures in healthy individuals
Int J Neuropsychopharmacol. 2025 05-Nov;():. 10.1093/ijnp/pyaf037
Ketamine
Modulation of functional network co-activation pattern dynamics following ketamine treatment in major depression
Imaging Neurosci (Camb). 2025 05-Nov;():. 10.1162/IMAG.a.936
Ketamine
A Phase 1 Assessment of Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers
Clin Pharmacol Ther. 2024 16-Jul;():. 10.1002/cpt.3391Ketamine
Baseline Cognitive Function Predicts Full Remission of Suicidal Symptoms Among Patients With Treatment-Resistant Depression & Suicidal Ideation After Low-Dose Ketamine Infusion
J Psychopharmacol. 2023 09-Sep;():. 10.1177/02698811231182107DMT
Psychological and physiological effects of extended DMT
J Psychopharmacol. 2024 05-Sep;():. 10.1177/02698811231196877
MDMA
Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination
Int J Neuropsychopharmacol. 2014 28-Sep;():. 10.1017/S1461145713001132
Psilocybin
Efficacy & Safety of Psychedelics for the Treatment of Mental Disorders
Psychiatry Res. 2024 05-Sep;():. 10.1016/j.psychres.2024.115886
Psilocybin
HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
J Pain Symptom Manage. 2023 05-Sep;():. 10.1016/j.jpainsymman.2023.06.006
MDMA
Safety & Efficacy of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, & Posttraumatic Stress Disorder
J Psychoactive Drugs. 2023 05-Sep;():. 10.1080/02791072.2023.2278586
Psilocybin
Microdosing With Psilocybin Mushrooms
Transl Psychiatry. 2022 05-Sep;():. 10.1038/s41398-022-02039-0
Psilocybin
Comparative Acute Effects of Mescaline, LSD, & Psilocybin in a Randomized, Double-Blind, Placebo-Controlled Cross-Over Study in Healthy Participants
Neuropsychopharmacology. 2023 05-Sep;():. 10.1038/s41386-023-01607-2
DMT
Acute Dose-Dependent Effects & Self-Guided Titration of Continuous N,N-Dimethyltryptamine Infusions
Neuropsychopharmacology. 2024 11-Jun;():. 10.1038/s41386-024-02041-8Showing 1-20 of 1001 results
1
2
3
4
5